Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rATG Induction and Maintenance in Kidney Transplant
NCT00556933Phase 4Completed
- Sponsor
- University of Nebraska
- Start
- Apr 2004
- Primary completion
- Apr 2011
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 4 trial of antithymocyte globulin, mycophenolate mofetil in kidney transplant rejection, sponsored by University of Nebraska. Started Apr 2004; status: completed.
02
Drugs
antithymocyte globulinmycophenolate mofetil
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00556933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00556933.